ReviewBipolar disorders2026
Speech and Language Markers of Bipolar Disorder: Challenges and Opportunities.
Review in Bipolar disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Speech and Language Markers of Bipolar Disorder: Challenges and Opportunities.Bipolar disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundClinicians aspire to predict the emergence of Bipolar Disorder (BD) in a timely manner. To accomplish this, markers reflecting mental states that can be gathered non-invasively and at large scale are needed. Here, we systematically evaluate evidence relating speech-based markers to mood states in BD.
methodsWe searched Medline and Google Scholar for all published studies in English up to February 2026 on the use of speech markers in BD. We undertook thematic analysis on abstracts using topic modeling and a qualitative gap analysis to identify potential opportunities for future research.
results43 out of 867 studies were included after screening. Topic analysis revealed an emerging focus on mapping mood states to automated speech features. Most studies focused on cross-sectional detection of bipolar mood states, or BD as a diagnosis, rather than the prediction of upcoming mood states. Speech features distinguished BD from schizophrenia, depression, and healthy controls. Manic states were characterized by quantifiable measures of pressured speech, derailment, grammatical errors, and word repetition; depressive states by an increased use of personal pronouns, reduced verbal fluency, and speech quantity. Overall, attempts to replicate observations were limited.
conclusionAcoustic and lexical-semantic markers vary with manic, psychotic, or depressive states. At present, the evidence is insufficient for clinical utility in relapse prediction, response monitoring, or diagnosing mixed episodes or state changes in BD. We recommend that future research leverages the growing capabilities of natural language processing through longitudinal and cross-linguistic studies to strengthen the evidence base and advance the clinical utility of speech markers for BD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.